Home » Reports » Clinigen Group PLC 21.3% Potential Upside Indicated by Liberum Capital

Clinigen Group PLC 21.3% Potential Upside Indicated by Liberum Capital

Clinigen Group PLC with EPIC/TICKER (LON:CLIN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Liberum Capital. Clinigen Group PLC are listed in the Health Care sector within AIM. Liberum Capital have set a target price of 1050 GBX on its stock. This is indicating the analyst believes there is a potential upside of 21.3% from today’s opening price of 865.5 GBX. Over the last 30 and 90 trading days the company share price has increased 174.5 points and increased 158.5 points respectively. The 1 year high for the share price is 1055 GBX while the 52 week low for the stock is 350.4 GBX.

Clinigen Group PLC has a 50 day moving average of 654.52 GBX and the 200 Day Moving Average price is recorded at 823.19. There are currently 132,848,758 shares in issue with the average daily volume traded being 553,017. Market capitalisation for LON:CLIN is £1,176,747,767 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn